VYNE Therapeutics Inc.VYNENASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank60
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.94
↑ 88% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-7.60
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.94 | +73.8% |
| 2024 | -3.58 | -325.7% |
| 2023 | -0.84 | -127.0% |
| 2022 | -0.37 | +48.2% |
| 2021 | -0.72 | +10.7% |
| 2020 | -0.80 | +64.1% |
| 2019 | -2.23 | -28.8% |
| 2018 | -1.74 | +91.5% |
| 2017 | -20.34 | +54.3% |
| 2016 | -44.46 | - |